AAAAAA

   
Results: 1-12 |
Results: 12
PHASE-I AND PHARMACOLOGICAL STUDY OF CONTINUOUS-INFUSION TOPOTECAN INCOMBINATION WITH CISPLATIN IN PATIENTS WITH ADVANCED CANCER - A CANCER AND LEUKEMIA GROUP-B STUDY
Authors: LILENBAUM RC MILLER AA BATIST G BERNARD S HOLLIS DR ROSNER GL EGORIN MJ SCHILSKY RL RATAIN MJ
Citation: Rc. Lilenbaum et al., PHASE-I AND PHARMACOLOGICAL STUDY OF CONTINUOUS-INFUSION TOPOTECAN INCOMBINATION WITH CISPLATIN IN PATIENTS WITH ADVANCED CANCER - A CANCER AND LEUKEMIA GROUP-B STUDY, Journal of clinical oncology, 16(10), 1998, pp. 3302-3309
PHASE-I STUDY OF PACLITAXEL AND ETOPOSIDE FOR METASTATIC OR RECURRENTMALIGNANCIES
Authors: LILENBAUM RC MACMANUS D ENGSTROM C GREEN M
Citation: Rc. Lilenbaum et al., PHASE-I STUDY OF PACLITAXEL AND ETOPOSIDE FOR METASTATIC OR RECURRENTMALIGNANCIES, American journal of clinical oncology, 21(2), 1998, pp. 129-134
SINGLE-AGENT VERSUS COMBINATION CHEMOTHERAPY IN PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CARCINOMA - A METAANALYSIS OF RESPONSE, TOXICITY,AND SURVIVAL
Authors: LILENBAUM RC LANGENBERG P DICKERSIN K
Citation: Rc. Lilenbaum et al., SINGLE-AGENT VERSUS COMBINATION CHEMOTHERAPY IN PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CARCINOMA - A METAANALYSIS OF RESPONSE, TOXICITY,AND SURVIVAL, Cancer, 82(1), 1998, pp. 116-126
INTERLEUKIN 2-INDUCED FOCAL FATTY INFILTRATE OF THE LIVER THAT MIMICSMETASTASES
Authors: LILENBAUM RC LILENBAUM AM HRYNIUK WM
Citation: Rc. Lilenbaum et al., INTERLEUKIN 2-INDUCED FOCAL FATTY INFILTRATE OF THE LIVER THAT MIMICSMETASTASES, Journal of the National Cancer Institute, 87(8), 1995, pp. 609-610
ISSUES AT THE CUTTING EDGE IN STAGE-III NON-SMALL-CELL LUNG-CANCER
Authors: GREEN MR LILENBAUM RC
Citation: Mr. Green et Rc. Lilenbaum, ISSUES AT THE CUTTING EDGE IN STAGE-III NON-SMALL-CELL LUNG-CANCER, Annals of oncology, 6, 1995, pp. 33-36
PHASE-I STUDY OF PACLITAXEL AND TOPOTECAN IN PATIENTS WITH ADVANCED TUMORS - A CANCER AND LEUKEMIA GROUP-B STUDY
Authors: LILENBAUM RC RATAIN MJ MILLER AA HARGIS JB HOLLIS DR ROSNER GL OBRIEN SM BREWSTER L GREEN MR SCHILSKY RL
Citation: Rc. Lilenbaum et al., PHASE-I STUDY OF PACLITAXEL AND TOPOTECAN IN PATIENTS WITH ADVANCED TUMORS - A CANCER AND LEUKEMIA GROUP-B STUDY, Journal of clinical oncology, 13(9), 1995, pp. 2230-2237
COPPER DEFICIENCY-INDUCED ANEMIA AND NEUTROPENIA SECONDARY TO INTESTINAL MALABSORPTION
Authors: HAYTON BA BROOME HE LILENBAUM RC
Citation: Ba. Hayton et al., COPPER DEFICIENCY-INDUCED ANEMIA AND NEUTROPENIA SECONDARY TO INTESTINAL MALABSORPTION, American journal of hematology, 48(1), 1995, pp. 45-47
A PHASE-I TRIAL OF PACLITAXEL AND ETOPOSIDE FOR METASTATIC OR RECURRENT MALIGNANCIES
Authors: GREEN MR MACMANUS DA LILENBAUM RC
Citation: Mr. Green et al., A PHASE-I TRIAL OF PACLITAXEL AND ETOPOSIDE FOR METASTATIC OR RECURRENT MALIGNANCIES, Seminars in oncology, 22(3), 1995, pp. 128-131
STAGE IIIA CATEGORY OF NON-SMALL-CELL LUNG-CANCER - A NEW PROPOSAL
Authors: GREEN MR LILENBAUM RC
Citation: Mr. Green et Rc. Lilenbaum, STAGE IIIA CATEGORY OF NON-SMALL-CELL LUNG-CANCER - A NEW PROPOSAL, Journal of the National Cancer Institute, 86(8), 1994, pp. 586-588
PHASE-I STUDY OF TOPOTECAN AND CISPLATIN IN PATIENTS WITH ADVANCED SOLID TUMORS - A CANCER AND LEUKEMIA GROUP-B STUDY
Authors: MILLER AA HARGIS JB LILENBAUM RC FIELDS SZ ROSNER GL SCHILSKY RL
Citation: Aa. Miller et al., PHASE-I STUDY OF TOPOTECAN AND CISPLATIN IN PATIENTS WITH ADVANCED SOLID TUMORS - A CANCER AND LEUKEMIA GROUP-B STUDY, Journal of clinical oncology, 12(12), 1994, pp. 2743-2750
SYSTEMIC TREATMENT OF KAPOSIS-SARCOMA - CURRENT STATUS AND FUTURE-DIRECTIONS
Authors: LILENBAUM RC RATNER L
Citation: Rc. Lilenbaum et L. Ratner, SYSTEMIC TREATMENT OF KAPOSIS-SARCOMA - CURRENT STATUS AND FUTURE-DIRECTIONS, AIDS, 8(2), 1994, pp. 141-151
NOVEL CHEMOTHERAPEUTIC-AGENTS IN THE TREATMENT OF NON-SMALL-CELL LUNG-CANCER
Authors: LILENBAUM RC GREEN MR
Citation: Rc. Lilenbaum et Mr. Green, NOVEL CHEMOTHERAPEUTIC-AGENTS IN THE TREATMENT OF NON-SMALL-CELL LUNG-CANCER, Journal of clinical oncology, 11(7), 1993, pp. 1391-1402
Risultati: 1-12 |